Effect of food consumption on pharmacokinetics of nilotinib in Chronic Myeloid Leukemia
Latest Information Update: 16 Jun 2021
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms NIFO
Most Recent Events
- 15 Jan 2019 New trial record
- 04 Dec 2018 Results assessing pharmacokinetics of nilotinib in chronic myeloid leukemia patients, presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.